Survey of Ophthalmology
Volume 51, Issue 1 , Pages 41-50 , January 2006

Primary Testicular and Intraocular Lymphomas: Two Case Reports and a Review of the Literature

  • Dana J. Wallace, BS

      Affiliations

    • National Eye Institute, NEI, Bethesda, Maryland, USA
    • ,
  • Chandra R. Altemare, MD

      Affiliations

    • National Eye Institute, NEI, Bethesda, Maryland, USA
    • ,
  • De Fen Shen, PhD

      Affiliations

    • National Eye Institute, NEI, Bethesda, Maryland, USA
    • ,
  • Marc D. deSmet

      Affiliations

    • Academic Center University of Amsterdam, the Netherlands
    • ,
  • Ronald R. Buggage, MD

      Affiliations

    • National Eye Institute, NEI, Bethesda, Maryland, USA
    • ,
  • Robert B. Nussenblatt, MD

      Affiliations

    • National Eye Institute, NEI, Bethesda, Maryland, USA
    • ,
  • Chi-Chao Chan, MD

      Affiliations

    • National Eye Institute, NEI, Bethesda, Maryland, USA
    • Corresponding Author InformationReprint address: Chi-Chao Chan, MD, Bldg. 10, Rm. 10N103, NIH/NEI, 10 Center Drive, Bethesda, MD 20892-1857

References 

  1. Abdel-Reheim FA, Edwards E, Arber DA. Utility of a rapid polymerase chain reaction panel for the detection of molecular changes in B-cell lymphoma. Arch Pathol Lab Med. 1996;120:357–363
  2. Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology. 1999;106:1805–1810
  3. Altman J, Winkelmann RK. Lymphosarcoma of the skin and testis. Arch Dermatol. 1960;82:943–947
  4. Armenakas NA, Schevchuk MM, Brodherson M, et al. AIDS presenting as primary testicular lymphoma. Urology. 1992;40:162–164
  5. Buzelin F, Karam G, Moreau A, et al. Testicular tumor and the acquired immunodeficiency syndrome. Eur Urol. 1994;26:71–76
  6. Cassoux N, Merle-Beral H, Leblond V, et al. Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm. 2000;8:243–250
  7. Cassoux N, Merle-Beral H, Lehoang P, et al. Interleukin-10 and intraocular-central nervous system lymphoma. Ophthalmology. 2001;108:426–427
  8. Chan CC. Molecular pathology of primary intraocular lymphomas. Trans Am Ophthalmol Soc. 2003;101:43–60
  9. Chan CC, Buggage RR, Nussenblatt RB. Intraocular lymphoma. Curr Opin Ophthalmol. 2002;13:411–418
  10. Chan CC, Whitcup SM, Solomon D, et al. Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol. 1995;120:671–673
  11. Chen YT, Whitney KD, Chen Y. Clonality analysis of B-cell lymphoma in fresh-frozen and paraffin-embedded tissues: the effects of variable polymerase chain reaction parameters. Mod Pathol. 1994;7:429–434
  12. Collins DH, Pugh RCB. Classification and frequency of testicular tumors. Br J Urol. 1964;36:1–11
  13. Connors JM. Problems in lymphoma management: special sites of presentation. Oncology. 1998;12:185–191discussion 192–5
  14. Connors JM, Klimo P, Voss N, et al. Testicular lymphoma: improved outcome with early brief chemotherapy. J Clin Oncol. 1988;6:776–781
  15. Corriveau C, Easterbrook M, Payne D. Lymphoma simulating uveitis (masquerade syndrome). Can J Ophthalmol. 1986;21:144–149
  16. Cui Z, Willingham MC. The effect of aging on cellular immunity against cancer in SR/CR mice. Cancer Immunol Immunother. 2004;53:473–478
  17. Curling TB (ed): A practical treatise on diseases of the testis. London, Churchill, 1878, ed 4
  18. Davis JL, Solomon D, Nussenblatt RB, et al. Immunocytochemical staining of vitreous cells. Indications, techniques, and results. Ophthalmology. 1992;99:250–256
  19. Davis JW, Moriarty RP, Schlossberg SM, et al. Bilateral testicular lymphoma treated with chemotherapy and radiation without orchiectomy: complete response relapsed at 52 months in the vitreous humor. Urology. 2001;57:555
  20. de Smet MD, Vancs VS, Kohler D, et al. Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma. Br J Ophthalmol. 1999;83:448–451
  21. DeAngelis LM. Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy. J Neurooncol. 1999;43:249–257
  22. DeAngelis LM. Brain tumors. N Engl J Med. 2001;344:114–123
  23. DeAngelis LM, Yahalom J, Thaler HT, et al. Combined modality therapy for primary CNS lymphoma. J Clin Oncol. 1992;10:635–643
  24. Doll DC, Weiss RB. Malignant lymphoma of the testis. Am J Med. 1986;81:515–524
  25. Ferguson TA, Green DR, Griffith TS. Cell death and immune privilege. Int Rev Immunol. 2002;21:153–172
  26. Ferry JA, Harris NL, Young RH, et al. Malignant lymphoma of the testis, epididymis, and spermatic cord. A clinicopathologic study of 69 cases with immunophenotypic analysis. Am J Surg Pathol. 1994;18:376–390
  27. Filippini A, Riccioli A, Padula F, et al. Control and impairment of immune privilege in the testis and in semen. Hum Reprod Update. 2001;7:444–449
  28. Fishburne BC, Wilson DJ, Rosenbaum JT, et al. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol. 1997;115:1152–1156
  29. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252–260
  30. Freeman LN, Schachat AP, Knox DL, et al. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology. 1987;94:1631–1639
  31. Gowing NFC. Malignant lymphoma of the testis. In:  Pugh RCB editors. Pathology of the Testis. London: Blackwell Scientific; 1976;p. 334–355
  32. Haddy TB, Sandlund JT, Magrath IT. Testicular involvement in young patients with non-Hodgkin's lymphoma. Am J Pediatr Hematol Oncol. 1988;10:224–229
  33. Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg. 1988;68:835–853
  34. Hockenbery D, Nuñez G, Milliman C, et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990;348:334–336
  35. Hoffman PM, McKelvie P, Hall AJ, et al. Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes. Eye. 2003;17:513–521
  36. Hormigo A, DeAngelis LM. Primary ocular lymphoma: clinical features, diagnosis, and treatment. Clin Lymphoma. 2003;4:22–29
  37. Inui J, Nakamine H, Nishihara T, et al. Extranodal lymphoma terminating in acute leukemia associated with IgD monoclonal gammopathy. A case report. Cancer. 1984;53:2487–2490
  38. Levy-Clarke GA, Byrnes GA, Buggage RR, et al. Primary intraocular lymphoma diagnosed by fine needle aspiration biopsy of a subretinal lesion. Retina. 2001;21:281–284
  39. Lopez JS, Chan CC, Burnier M, et al. Immunohistochemistry findings in primary intraocular lymphoma. Am J Ophthalmol. 1991;112:472–474
  40. Malassez M. Lymphadenome Due Testicule. Bull Soc Anta. 1877;52:176–178
  41. Margolis L, Fraser R, Lichter A, et al. The role of radiation therapy in the management of ocular reticulum cell sarcoma. Cancer. 1980;45:688–692
  42. Merle-Béral H, Davi F, Cassoux N, et al. Biological diagnosis of primary intraocular lymphoma. Br J Haematol. 2004;124:469–473
  43. Møller MB, d'Amore F, Christensen BE. Testicular lymphoma: a population-based study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO. Eur J Cancer. 1994;30A:1760–1764
  44. Mostofi FK. Secondary tumors initially manifest as testicular neoplasms. In:  Mostofi FK,  Price EB editor. Tumors of the Male Genital System. Washington, DC: Armed Forces Institute of Pathology; 1973;p. 131–136
  45. Mullaney J. Peculiar ophthalmic proliferations. Eye. 1990;4(Pt 1):79–88
  46. Ngan BY, Chen-Levy Z, Weiss LM, et al. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation. N Engl J Med. 1988;318:1638–1644
  47. Paladugu RR, Bearman RM, Rappaport H. Malignant lymphoma with primary manifestation in the gonad: a clinicopathologic study of 38 patients. Cancer. 1980;45:561–571
  48. Paulus W. Classification, pathogenesis and molecular pathology of primary CNS lymphomas. J Neurooncol. 1999;43:203–208
  49. Poulsen MG, Roberts SJ, Taylor K. Testicular lymphoma—the need for a new approach. Australas Radiol. 1991;35:257–260
  50. Raju VK, Green WR. Reticulum cell sarcoma of the uvea. Ann Ophthalmol. 1982;14:555–560
  51. Read G. Lymphomas of the testis-results of treatment 1960–77. Clin Radiol. 1981;32:687–692
  52. Rothova A, Ooijman F, Kerkhoff F, et al. Uveitis masquerade syndromes. Ophthalmology. 2001;108:386–399
  53. Sampat MB, Sirsat MV, Kamat MR. Malignant lymphoma of the testis in Indians. Br J Urol. 1974;46:569–575
  54. Schabet M. Epidemiology of primary CNS lymphoma. J Neurooncol. 1999;43:199–201
  55. Shahab N, Doll DC. Testicular lymphoma. Semin Oncol. 1999;26:259–269
  56. Shen DF, Zhuang Z, LeHoang P, et al. Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. Ophthalmology. 1998;105:1664–1669
  57. Siegel MJ, Dalton J, Friedman AH, et al. Ten-year experience with primary ocular ‘reticulum cell sarcoma’ (large cell non-Hodgkin's lymphoma). Br J Ophthalmol. 1989;73:342–346
  58. Smith JR, Rosenbaum JT, Wilson DJ, et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology. 2002;109:1709–1716
  59. Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol. 2003;3:879–889
  60. Sussman EB, Hajdu SI, Lieberman PH, et al. Malignant lymphoma of the testis: a clinicopathologic study of 37 cases. J Urol. 1977;118:1004–1007
  61. Touroutoglou N, Dimopoulos MA, Younes A, et al. Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy. J Clin Oncol. 1995;13:1361–1367
  62. Turley HK, Moore TD. Malignant lymphoma primarily manifested as a testicular tumor. J Urol. 1952;68:744–746
  63. Turner RR, Colby TV, MacKintosh FR. Testicular lymphomas: a clinicopathologic study of 35 cases. Cancer. 1981;48:2095–2102
  64. Velez G, Chan CC, Csaky KG. Fluorescein angiographic findings in primary intraocular lymphoma. Retina. 2002;22:37–43
  65. Velez G, de Smet MD, Whitcup SM, et al. Iris involvement in primary intraocular lymphoma: report of two cases and review of the literature. Surv Ophthalmol. 2000;44:518–526
  66. Vogel MH, Font RL, Zimmerman LE, et al. Reticulum cell sarcoma of the retina and uvea. Report of six cases and review of the literature. Am J Ophthalmol. 1968;66:205–215
  67. Weiss LM, Warnke RA, Sklar J, et al. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med. 1987;317:1185–1189
  68. Whitcup SM, de Smet MD, Rubin BI, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology. 1993;100:1399–1406
  69. Whitcup SM, Stark-Vancs V, Wittes RE, et al. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Arch Ophthalmol. 1997;115:1157–1160
  70. Wolf LA, Reed GF, Buggage RR, et al. Vitreous cytokine levels. Ophthalmology. 2003;110:1671–1672
  71. Woolley PV, Osborne CK, Levi JA, et al. Extranodal presentation of non-Hodgkin's lymphomas in the testis. Cancer. 1976;38:1026–1035
  72. Yunis JJ, Oken MM, Kaplan ME, et al. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med. 1982;307:1231–1236
  73. Zietman AL, Coen JJ, Ferry JA, et al. The management and outcome of stage IAE nonHodgkin's lymphoma of the testis. J Urol. 1996;155:943–946

 The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(05)00193-1

doi: 10.1016/j.survophthal.2005.11.002

Survey of Ophthalmology
Volume 51, Issue 1 , Pages 41-50 , January 2006

Article Tools

* Image Usage & Resolution